TIBET EASTMONEY FUTIBET EASTMONEY FUTIBET EASTMONEY FU

TIBET EASTMONEY FU

No trades
See on Supercharts

Key stats


Assets under management (AUM)
Fund flows (1Y)
Dividend yield (indicated)
Discount/Premium to NAV
Shares outstanding
Expense ratio
0.55%

About TIBET EASTMONEY FU


Issuer
Tibet Oriental Wealth Securities Co., Ltd.
Brand
Dongcai
Inception date
Apr 21, 2023
Structure
Open-Ended Fund
Index tracked
CSI Shanghai-Hong Kong-Shenzhen Innovative Drug Industry Index - CNY - Benchmark TR Gross
Management style
Passive
ISIN
CNE100005YZ1
Tightly track the target index, pursue the minimization of tracking deviation and tracking err.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharmaceuticals
Strategy
Vanilla
Geography
China
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of June 30, 2024
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks98.34%
Health Technology93.72%
Commercial Services4.62%
Bonds, Cash & Other1.66%
Cash1.66%
Stock breakdown by region
100%
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows